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Abstract 
Background: Lamotrigine is an effective anticonvulsant drug that has also been demonstrated to be effective in the 
treatment of bipolar disorder. We report a case of rhabdomyolysis after intentional overdose in a woman aged 48.
Case presentation: A 48-year-old female presented to the emergency department after an acute ingestion of 6 g of 
lamotrigine. The patient suffered from bipolar disorder, and she was taking lamotrigine and olanzapine. At that point, 
she had a major depressive episode, and she wanted to commit suicide. Activated charcoal was administered in the 
emergency department. Her vital signs were still normal, and she entered the Medical clinic, where she had been 
there for 2 days in a good condition. The hematological and biochemical results were normal. On the fourth day, the 
levels of creatine phosphokinase (CPK) showed remarkable increase (2500 IU/ml). Fluid and bicarbonate intravenous 
administration was performed, and CPK levels returned to normal after 3 days.
Conclusion: The majority of patients exposed to lamotrigine in overdose experienced no toxic clinical effects. The 
most common clinical effects are drowsiness and lethargy, vomiting, nausea, ataxia, dizziness/vertigo, and tachycar-
dia. In this case report, the patient was alert and did not have any serious complications, except for mild rhabdomy-
olysis, which was the main consequence of lamotrigine overdose.
Keywords: Lamotrigine, Overdose, Rhabdomyolysis
© 2016 Karaoulanis et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Antiepileptic drugs are being used across a wider num-
ber of indications, including bipolar affective disorders 
and other psychiatric diseases. Carbamazepine, val-
proate, and lamotrigine have demonstrated efficacy in 
the treatment of acute mania and are capable of prevent-
ing relapse in patients with bipolar disorder. In view of 
all these factors, there has been more widespread use of 
antiepileptic drugs in patients with underlying psychi-
atric disorders, often as an unlicensed indication. This 
patient group is at substantially increased risk of self 
poisoning.
We present the case of mild rhabdomyolysis that was 
caused by lamotrigine overdose in a patient suffering 
from bipolar disorder.
Case presentation
A 48-year-old female patient presented to the emer-
gency department after an acute ingestion of 30 tablets 
of 200 mg lamotrigine. The patient suffered from bipolar 
disorder, and she was also taking olanzapine and oxcar-
bazepine. Nevertheless, she admitted that she stopped 
taking her medication 2 months ago. She said that lamo-
trigine was the only drug that she had ingested. An empty 
box containing 30 lamotrigine pills was found next to her 
bed. The patient was alone when she swallowed the pills. 
Her daughter told us that her mother had been very sad 
for a period of 10 days because her son had died because 
of heroin overdose. Afterward, her mother told her that 
there was no reason for her to live and to continue tak-
ing her medication. Consequently, it seems more possi-
ble that the patient did not take any other medication. A 
toxicologic analysis would have been useful in this case, 
but unfortunately it was never done.
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There was no history of illicit drug use or alcoholism, 
apart from smoking.
The patient was alert and her blood pressure, pulse 
rate, and temperature were within normal limits. The 
neurologic examination disclosed no focal findings.
Gastric lavage with activated charcoal was adminis-
tered. Hematological and biochemical examinations, 
including liver function tests, were normal. Her electro-
cardiogram did not reveal any abnormalities. Then, the 
patient was admitted to the Medical Clinic, in order to 
ensure the early detection of any side effects of the high 
dose of lamotrigine. She remained at the Medical Clinic 
for 2 days. On the third day, as long as she did not face 
any problem (the blood and biochemical studies were 
normal), she was transferred to the Psychiatric Clinic.
The biochemical studies which were carried out in the 
Psychiatric Clinic showed that the value of creatine phos-
phokinase (CPK) was 620 IU/ml (normal 24-204 IU/ml). 
The following day CPK levels reached 2500 IU/ml.
Fluid and bicarbonate intravenous administration was 
performed, and 3  days later, CPK returned to normal 
levels.
She was depressed and wanted to commit suicide 
because of the death of her son. She was suffering from 
bipolar disorder but did not comply with her pharmaco-
logical treatment.
Review of the literature
The most common clinical effects arising from lamo-
trigine overdose are drowsiness and lethargy, vomiting, 
nausea, ataxia, nystagmus, dizziness/vertigo, and tachy-
cardia. Major clinical effects, which are rare, include 
coma, seizures, respiratory depression, cardiovascular 
shock, and multi-organ systemic allergic-type reaction 
[1–11]. In all these case reports, lamotrigine was com-
bined with other drugs. However, Moore et al. reported 
a case series of patients with lamotrigine only overdose, 
and they had found that the consequences were seizures, 
hypertension, tachycardia, tachypnea, altered mental sta-
tus, myoclonus, and QRS prolongation [10]. In two cases, 
the patients died, but in one case, there was a multiple 
drug overdose (lamotrigine, ethanol, thioridazine, carba-
mazepine, and paroxetine) (Table 1) [11, 12].
The outcome of lamotrigine overdose depends on a 
variety of factors, like the age, sex, the medical disease, 
and the simultaneous ingestion of other medications. The 
age is very important for the clinical outcome of lamo-
trigine overdose. It seems that in children, the ingestion 
of high amount of lamotrigine causes generalized sei-
zures [13–15]. In adults, seizures are reported [16], but 
not so often like in children.
Another important factor for the clinical picture of 
lamotrigine overdose is the disease of the patient who 
was taking lamotrigine. The majority of patients suffered 
from epilepsy. In these cases, lamotrigine, usually, caused 
seizures [16, 17]. On the contrary, in patients with bipo-
lar disorder, seizures might not be so frequent result [18, 
19]. In one case report, a bipolar patient who co-ingested 
lamotrigine and ethanol developed epileptic seizures 
[20]. However, it is noteworthy that a bipolar patient pre-
sented with anticonvulsant hypersensitivity syndrome 
(including symptoms such as fever, rash, and hepatitis) 
after lamotrigine overdose [19].
The combination of lamotrigine with other medications 
must be taken into account in the cases of lamotrigine 
overdose. It is combined, usually, with other antiepilep-
tic drugs, with antidepressant drugs and with antipsy-
chotic drugs. In these cases, the level of consciousness is 
disturbed (reduced level of consciousness, stupor, coma, 
etc.) [17, 18, 20–22], and cardiovascular collapse may be 
present [23] Concerning the sex, women are more likely 
to ingest large amounts of lamotrigine than men [24].
The patient, who was presented above, ingested 6  g 
of lamotrigine. This is one of the largest amounts of 
lamotrigine ingested alone, ever reported. This patient 
developed only mild rhabdomyolysis without any other 
clinical outcome. Mild rhabdomyolysis is also reported in 
another case report [20], in which the amount of lamo-
trigine was unknown and the patient presented with epi-
leptic seizures. Consequently, the authors did not know 
whether rhabdomyolysis was primary or the result of sei-
zures. In our case, rhabdomyolysis appeared without sei-
zures. Therefore, it seems that mild rhabdomyolysis is the 
primary outcome of lamotrigine overdose.
In this case, the pathogenic mechanism of rhabdo-
myolysis is not clear. It could be hypothesized that the 
overdose of lamotrigine led to rhabdomyolysis due to a 
genetic predisposition. For example, it was found that 
patients with virally induced rhabdomyolysis had malig-
nant hyperthermia susceptibility (MHS)-associated.
RYR1 mutations [25, 26]. Therefore, in our case maybe 
the combination of environmental and genetic factors 
caused rhabdomyolysis [27].
In general, the ingestion of 6 g of lamotrigine did not 
cause any serious clinical effect on our patient. This is an 
important factor for patients with bipolar disorder who 
are prone to suicidal ideation and commitment of sui-
cide—because these patients might try to commit sui-
cide by taking excessive amounts of medications which 
are given to them by doctors in order to treat their prob-
lem. In addition, lamotrigine protects bipolar patients 
from the influence of depressive episodes, which are the 
cause of suicidal ideation. Lithium is another agent used 
in bipolar disorder, which has proven to be an effective 
deterrent against the suicidal tendency of these patients. 
However, lithium has serious adverse effects which limit 
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its use. On the contrary, lamotrigine, when it is titrated 
slowly to avoid Stevens Johnson syndrome, seems to be a 
drug without any serious adverse effects. It is noteworthy 
that lamotrigine has been found to be one of the safest 
antiepileptic drugs in pregnancy [28].
Conclusions
In conclusion, mild rhabdomyolysis seems to be a pri-
mary effect of lamotrigine overdose, and lamotrigine 
appears to be quite safe in the case of overdose, especially 
when it is not combined with other medications.
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